Skip to content
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
Solutions
Therapeutics
Aesthetics
Breast implants
Dermal reconstruction
Nevelia
Nevelia Pro
Surgical procedure
Clinical cases
Clinical data publications
Live webinars
Videos
Brochures
Black and Black Surgical
Administration systems
B2B administration systems
administration systems SD products
Therapeutics
Aesthetics ESTYME®
Administration systems
Impact
CSR commitments and objectives
Symatese Foundation
Symatese Charters
News
Careers
Contact
Linkedin-in
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
Solutions
Therapeutics
Aesthetics ESTYME®
Administration systems
Impact
CSR commitments and objectives
Symatese Foundation
Symatese Charters
News
Careers
Contact
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
Solutions
Therapeutics
Aesthetics ESTYME®
Administration systems
Impact
CSR commitments and objectives
Symatese Foundation
Symatese Charters
News
Careers
Contact
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
SOLUTIONS
THERAPEUTICS
Therapeutics
Dermal Reconstruction
NEVELIA®
NEVELIA® Pro
AESTHETIC ESTYME®
Aesthethics
ESTYME Dermal fillers
ESTYME Breast implants
Black and black surgical
AESTHETIC SEBBIN
Aesthethics
SEBBIN Breast implants
SEBBIN Body implants
SEBBIN Custom made implants
SEBBIN Lipofliting
Administration systems
Administration systems
B2B Administration systems
Administration system SD products
IMPACT
CSR commitments and objectives
Symatese Foundation
Symatese Charters
NEWS
View our latests news
CAREERS
View open positions
CONTACT
Get in touch
Category: Administratif
SYMATESE announces the commercial Launch of Evolysse™ in the US
April 17, 2025
SYMATESE Secures FDA Approval for EVOLYSSE™
February 14, 2025
SYMATESE previews COLD-X™ TECHNOLOGY at IMCAS
February 7, 2025
SYMATESE DEVICE invites you to Pharmapack 2025
January 3, 2025
SYMATESE reaches a decisive milestone!
October 31, 2024
SYMATESE Announces Submission to U.S. FDA for its Pre-market approval Application for its HA dermal fillers
June 25, 2024
